Bettina K Andreassen
Overview
Explore the profile of Bettina K Andreassen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hektoen H, Tsuruda K, Fjellbirkeland L, Nilssen Y, Brustugun O, Andreassen B
Br J Cancer
. 2024 Nov;
132(1):93-102.
PMID: 39489879
Background: Based on favourable results from clinical trials, immune checkpoint inhibitors (ICI) have become the standard first line (1 L) systemic anticancer treatment (SACT) for advanced stage non-small cell lung...
2.
Shala N, Stenehjem J, Babigumira R, Liu F, Berge L, Silverman D, et al.
Br J Cancer
. 2023 Jul;
129(5):838-851.
PMID: 37464024
Background: Occupational exposures constitute the second leading cause of urinary bladder cancer after tobacco smoking. Increased risks have been found in the petroleum industry, but high-quality exposure data are needed...
3.
Kristensen K, Friis S, Lund L, Hallas J, Cardwell C, Andreassen B, et al.
Cancer Res Commun
. 2023 Mar;
2(6):552-560.
PMID: 36923552
Significance: This study provides a screening tool for drug carcinogenicity aimed at hypothesis generation and explorative purposes. As such, the study may help to identify drugs with unknown carcinogenic effects...
4.
Ghiasvand R, Berge L, Andreassen B, Green A, Al Rahmoun M, Fournier A, et al.
Br J Dermatol
. 2023 Mar;
188(6):805-807.
PMID: 36866569
No abstract available.
5.
Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
Ghiasvand R, Berge L, Andreassen B, Stenehjem J, Heir T, Karlstad O, et al.
Int J Epidemiol
. 2022 Nov;
52(3):887-898.
PMID: 36413027
Background: Most antihypertensives can induce dermal photosensitivity, which may increase melanoma risk. However, corroborating evidence is limited. We examined the associations between use of antihypertensives and melanoma risk. Methods: A...
6.
Guderud K, Sunde L, Flam S, Maehlen M, Mjaavatten M, Norli E, et al.
Front Immunol
. 2021 Dec;
12:713611.
PMID: 34867944
Background: Methotrexate (MTX) is the first line treatment of rheumatoid arthritis (RA), and methylation changes in bulk T cells have been reported after treatment with MTX. We have investigated cell-type...
7.
Andreassen B, Hektoen H, Axcrona K, Langseth H, Stenehjem J, Robsahm T
Clin Epidemiol
. 2021 Nov;
13:1061-1062.
PMID: 34803404
No abstract available.
8.
Hektoen H, Gislefoss R, Stenehjem J, Langseth H, Axcrona K, Mondul A, et al.
Clin Epidemiol
. 2021 Sep;
13:801-811.
PMID: 34548821
Purpose: Circulating 25-hydroxyvitamin D (25(OH)D) is inversely associated with overall cancer mortality and selected cancers, while for urothelial bladder cancer (BC) this relationship is unclear. We aimed to examine the...
9.
Stoer N, Bouche G, Pantziarka P, Sloan E, Andreassen B, Botteri E
Acta Oncol
. 2021 Aug;
60(9):1146-1153.
PMID: 34338111
Background: The prognosis of pancreatic cancer is poor and new treatment strategies are urgently needed. To identify non-cancer drugs that could be re-purposed for cancer, we investigated the association between...
10.
Hektoen H, Robsahm T, Stenehjem J, Axcrona K, Babigumira R, Mondul A, et al.
Cancer Med
. 2021 Jun;
10(12):4107-4116.
PMID: 34080787
Background: High circulating levels of vitamin D (25(OH)D) are suggested to reduce the risk of urinary bladder cancer (BC), but the evidence is weak, and several studies lack sufficient adjustment...